FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3217066905> ?p ?o ?g. }

• W3217066905 abstract "Abstract Background Convalescent plasma has been widely used to treat COVID-19 and is under investigation in numerous randomized clinical trials, but results are publicly available only for a small number of trials. The objective of this study was to assess the benefits of convalescent plasma treatment compared to placebo or no treatment and all-cause mortality in patients with COVID-19, using data from all available randomized clinical trials, including unpublished and ongoing trials (Open Science Framework, https://doi.org/10.17605/OSF.IO/GEHFX ). Methods In this collaborative systematic review and meta-analysis, clinical trial registries (ClinicalTrials.gov, WHO International Clinical Trials Registry Platform), the Cochrane COVID-19 register, the LOVE database, and PubMed were searched until April 8, 2021. Investigators of trials registered by March 1, 2021, without published results were contacted via email. Eligible were ongoing, discontinued and completed randomized clinical trials that compared convalescent plasma with placebo or no treatment in COVID-19 patients, regardless of setting or treatment schedule. Aggregated mortality data were extracted from publications or provided by investigators of unpublished trials and combined using the Hartung–Knapp–Sidik–Jonkman random effects model. We investigated the contribution of unpublished trials to the overall evidence. Results A total of 16,477 patients were included in 33 trials (20 unpublished with 3190 patients, 13 published with 13,287 patients). 32 trials enrolled only hospitalized patients (including 3 with only intensive care unit patients). Risk of bias was low for 29/33 trials. Of 8495 patients who received convalescent plasma, 1997 died (23%), and of 7982 control patients, 1952 died (24%). The combined risk ratio for all-cause mortality was 0.97 (95% confidence interval: 0.92; 1.02) with between-study heterogeneity not beyond chance (I 2 = 0%). The RECOVERY trial had 69.8% and the unpublished evidence 25.3% of the weight in the meta-analysis. Conclusions Convalescent plasma treatment of patients with COVID-19 did not reduce all-cause mortality. These results provide strong evidence that convalescent plasma treatment for patients with COVID-19 should not be used outside of randomized trials. Evidence synthesis from collaborations among trial investigators can inform both evidence generation and evidence application in patient care." @default.
• W3217066905 created "2021-12-06" @default.
• W3217066905 creator A5000360404 @default.
• W3217066905 creator A5000889113 @default.
• W3217066905 creator A5001596111 @default.
• W3217066905 creator A5003340316 @default.
• W3217066905 creator A5004509184 @default.
• W3217066905 creator A5004614378 @default.
• W3217066905 creator A5004848608 @default.
• W3217066905 creator A5004940785 @default.
• W3217066905 creator A5005004880 @default.
• W3217066905 creator A5005119582 @default.
• W3217066905 creator A5006255440 @default.
• W3217066905 creator A5007275245 @default.
• W3217066905 creator A5007610713 @default.
• W3217066905 creator A5008197383 @default.
• W3217066905 creator A5008447327 @default.
• W3217066905 creator A5010273507 @default.
• W3217066905 creator A5011023321 @default.
• W3217066905 creator A5011578307 @default.
• W3217066905 creator A5011825582 @default.
• W3217066905 creator A5011933409 @default.
• W3217066905 creator A5012228981 @default.
• W3217066905 creator A5012247737 @default.
• W3217066905 creator A5012442580 @default.
• W3217066905 creator A5012521967 @default.
• W3217066905 creator A5012525384 @default.
• W3217066905 creator A5012545427 @default.
• W3217066905 creator A5013030521 @default.
• W3217066905 creator A5013108036 @default.
• W3217066905 creator A5013414693 @default.
• W3217066905 creator A5013551077 @default.
• W3217066905 creator A5013604261 @default.
• W3217066905 creator A5013790293 @default.
• W3217066905 creator A5014769143 @default.
• W3217066905 creator A5014769503 @default.
• W3217066905 creator A5015876613 @default.
• W3217066905 creator A5015902606 @default.
• W3217066905 creator A5016129673 @default.
• W3217066905 creator A5016205983 @default.
• W3217066905 creator A5016246504 @default.
• W3217066905 creator A5016310911 @default.
• W3217066905 creator A5016423074 @default.
• W3217066905 creator A5018187334 @default.
• W3217066905 creator A5018380807 @default.
• W3217066905 creator A5018443612 @default.
• W3217066905 creator A5018640235 @default.
• W3217066905 creator A5019149886 @default.
• W3217066905 creator A5019348706 @default.
• W3217066905 creator A5019364319 @default.
• W3217066905 creator A5020160224 @default.
• W3217066905 creator A5020459997 @default.
• W3217066905 creator A5020786234 @default.
• W3217066905 creator A5020920278 @default.
• W3217066905 creator A5021313018 @default.
• W3217066905 creator A5021608730 @default.
• W3217066905 creator A5021692759 @default.
• W3217066905 creator A5021959578 @default.
• W3217066905 creator A5022068495 @default.
• W3217066905 creator A5022191498 @default.
• W3217066905 creator A5022367224 @default.
• W3217066905 creator A5023103534 @default.
• W3217066905 creator A5023141160 @default.
• W3217066905 creator A5023790580 @default.
• W3217066905 creator A5024314846 @default.
• W3217066905 creator A5025530641 @default.
• W3217066905 creator A5025830668 @default.
• W3217066905 creator A5027607560 @default.
• W3217066905 creator A5028388949 @default.
• W3217066905 creator A5029546143 @default.
• W3217066905 creator A5029711029 @default.
• W3217066905 creator A5031053638 @default.
• W3217066905 creator A5031296300 @default.
• W3217066905 creator A5032256789 @default.
• W3217066905 creator A5032364054 @default.
• W3217066905 creator A5032395567 @default.
• W3217066905 creator A5033096500 @default.
• W3217066905 creator A5033683552 @default.
• W3217066905 creator A5033723956 @default.
• W3217066905 creator A5034534923 @default.
• W3217066905 creator A5035540222 @default.
• W3217066905 creator A5036271514 @default.
• W3217066905 creator A5036445040 @default.
• W3217066905 creator A5036459628 @default.
• W3217066905 creator A5036551430 @default.
• W3217066905 creator A5036787987 @default.
• W3217066905 creator A5037474313 @default.
• W3217066905 creator A5039350794 @default.
• W3217066905 creator A5039893748 @default.
• W3217066905 creator A5039922626 @default.
• W3217066905 creator A5040004837 @default.
• W3217066905 creator A5040011900 @default.
• W3217066905 creator A5041023184 @default.
• W3217066905 creator A5041497834 @default.
• W3217066905 creator A5041667780 @default.
• W3217066905 creator A5041812429 @default.
• W3217066905 creator A5042460457 @default.
• W3217066905 creator A5042719796 @default.
• W3217066905 creator A5042951039 @default.
• W3217066905 creator A5043016485 @default.

• next